Medication Updates

Health Canada has initiated a safety review on Xeljanz and Xeljanz XR (tofacitinib), used to treat arthritis and ulcerative colitis, From Government of Canada, Recalls and Safety Alerts, April 6, 2021

Drug Safety Advisories: A Need for International Coordination, From Therapeutics Initiative, Dec. 3, 2020.

Drug Picato has been withdrawn from use in Canada due to potential increased risk of skin cancer. From Government of Canada, Recalls and safety alerts, October 27, 2020.

health-product-infowatch-november-2020-health-canada